Drugs / NKF-INS(L)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07165652 | Oct 2025 → Mar 2026 | — | Xentria, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NKF-INS(L) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07165652 ↗ |